Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-11-26

Clinical Trial Update: The PulsePoint Randomized Controlled Trial [NA]

View source ↗

Summary

The PulsePoint randomized controlled trial sponsored by Queen's University has been withdrawn; it concerned out-of-hospital cardiac arrest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Queen's University | Conditions: Out-of-hospital Cardiac Arrest | NA | Status: WITHDRAWN